Cutaneous ulceration as a sign of methotrexate toxicity
Del Pozo, J.; Martínez, W.; García-Silva, J.; Almagro, M.; Peña-Penabad, C.; Fonseca, E.
European Journal of Dermatology Ejd 11(5): 450-452
2001
ISSN/ISBN: 1167-1122 PMID: 11525955 Document Number: 529440
Methotrexate (MTX) inhibits DNA synthesis by competition with dihydrofolate reductase. Adverse cutaneous reactions to MTX are usually dose-related and have been mainly reported in patients receiving extremely large doses of chemotherapy. Painful erosion of psoriatic plaques has been often reported as an early sign of MTX toxicity, but cutaneous ulceration as a sign of MTX toxicity in patients without psoriasis has only been described in one case. We report a patient with rheumatoid arthritis and without psoriasis who developed cutaneous ulceration on the knuckles as a sign of MTX toxicity. Cutaneous ulceration by MTX toxicity is an exclusion diagnosis and its pathogenic mechanism may be multifactorial, including direct toxicity of the drug in addition to local factors.